1
/
of
1
Elabscience
SKU:PKSH033870
Recombinant Human Tie-2 (C-Fc)
Recombinant Human Tie-2 (C-Fc)
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human Tie-2 (C-FC), a cutting-edge product that revolutionizes the field of biotechnology. This meticulously engineered solution showcases the pinnacle of scientific innovation, offering unparalleled efficacy and reliability.
The Recombinant Human Tie-2 (C-FC) is a result of extensive research and development, meticulously crafted to meet the highest standards of quality and performance. This product is derived from recombinant DNA technology, ensuring its purity and consistency, making it an ideal choice for various applications in the biomedical and pharmaceutical industries.
With its exceptional binding affinity and specificity, the Recombinant Human Tie-2 (C-FC) exhibits remarkable potential in therapeutic interventions. Its ability to modulate angiogenesis and vascular remodeling processes makes it an invaluable tool in the treatment of various diseases, including cancer, cardiovascular disorders, and ocular pathologies.
This product's unique formulation enables precise targeting and activation of Tie-2 receptors, facilitating the regulation of endothelial cell functions. By promoting angiogenesis and vascular stabilization, the Recombinant Human Tie-2 (C-FC) contributes to tissue repair and regeneration, offering promising prospects for regenerative medicine and tissue engineering.
Furthermore, the Recombinant Human Tie-2 (C-FC) boasts exceptional stability and solubility, ensuring ease of handling and storage. Its high bioactivity and potency guarantee consistent and reproducible results, making it an indispensable asset for researchers and scientists alike.
In conclusion, the Recombinant Human Tie-2 (C-FC) represents a groundbreaking advancement in the realm of biotechnology. Its unrivaled efficacy, purity, and versatility make it an indispensable tool for various applications in the biomedical and pharmaceutical sectors. Embrace the future of scientific progress with the Recombinant Human Tie-2 (C-FC) and unlock a world of possibilities in the pursuit of improved healthcare and well-being.
The Recombinant Human Tie-2 (C-FC) is a result of extensive research and development, meticulously crafted to meet the highest standards of quality and performance. This product is derived from recombinant DNA technology, ensuring its purity and consistency, making it an ideal choice for various applications in the biomedical and pharmaceutical industries.
With its exceptional binding affinity and specificity, the Recombinant Human Tie-2 (C-FC) exhibits remarkable potential in therapeutic interventions. Its ability to modulate angiogenesis and vascular remodeling processes makes it an invaluable tool in the treatment of various diseases, including cancer, cardiovascular disorders, and ocular pathologies.
This product's unique formulation enables precise targeting and activation of Tie-2 receptors, facilitating the regulation of endothelial cell functions. By promoting angiogenesis and vascular stabilization, the Recombinant Human Tie-2 (C-FC) contributes to tissue repair and regeneration, offering promising prospects for regenerative medicine and tissue engineering.
Furthermore, the Recombinant Human Tie-2 (C-FC) boasts exceptional stability and solubility, ensuring ease of handling and storage. Its high bioactivity and potency guarantee consistent and reproducible results, making it an indispensable asset for researchers and scientists alike.
In conclusion, the Recombinant Human Tie-2 (C-FC) represents a groundbreaking advancement in the realm of biotechnology. Its unrivaled efficacy, purity, and versatility make it an indispensable tool for various applications in the biomedical and pharmaceutical sectors. Embrace the future of scientific progress with the Recombinant Human Tie-2 (C-FC) and unlock a world of possibilities in the pursuit of improved healthcare and well-being.
Share
